The Centre’s fiscal deficit for April-November 2020 soared to Rs 10.76 lakh crore, or 135 percent of the full year budgeted target of Rs 7.96 lakh crore, as the government’s finances continued to be stretched due to lower revenues arising from the COVID-19 pandemic and the economic slowdown.
What is noticeable, however, is that while expenditure in November shot up to be the highest in five months, overall consolidated spending levels are much below what analysts expect in a year when there has been clamour for increased public spending.
Total expenditure for the first eight months of the current fiscal year was Rs 19.06 lakh crore or 62 percent of the budget size of Rs 30 lakh crore. This compares to 65.3 percent for the same period last year, when total expenditure for April-November 2019 was Rs 18.20 lakh crore versus a budget size of Rs 27.9 lakh crore.
While the Centre has increased its capital and revenue spending commitments as part of the Aatmanirbhar Bharat and Gareeb Kalyan announcements, it is clear that some expenditure rationalization is taking place as well.
“This year, they have more justification than ever to ramp up public expenditure. They can take the fiscal deficit to 10 per cent of GDP, owing to higher deficit and lower GDP, and it would be perfectly understandable. However, the Centre is not spending as much as it should,” said an independent economist. The person did not wish to be named as he currently advises the government on a number of matters.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
"Revenue expenditure on fertilizers, defence, education and petroleum have been lower in the current financial year from that in the previous year," said Madan Sabnavis, Chief Economist with Care Ratings.
The good news for November was that the Centre’s expenditure was the second highest this year at Rs 2.45 lakh crore. It was in November that Finance Minister Nirmala Sitharaman announced the ‘Aatmanirbhar Bharat 3.0’ set of announcements. The immediate fiscal outlay for those measures is expected to be Rs 1.5 lakh crore.
“While capex growth has improved to an encouraging 13 percent, revenue expenditure growth has been curtailed to 4 per cent in April-November 2020. The continuing considerable 17 percent decline in revenue receipts coupled with the subdued disinvestment receipts has engendered the massive fiscal deficit in FY20 so far,” said Aditi Nayar, Principal Economist with ICRA Ltd.
“The month of November saw a sharp and encouraging ramping up of the Government of India's spending, with the monthly outgo recording a year-on-year expansion of 32 per cent for revenue expenditure and nearly 250 per cent on a small base for capital expenditure. A sustenance of this trend will bolster economic activity, and help the Indian economy exit the recession in the coming quarter,” she said.
Nayar said she estimates the Centre’s total expenditure at Rs 30.2 lakh crore for the full year, mildly lower than the budgeted level, despite the fiscal support measures that have been announced so far. This translates into a projected expenditure of Rs 11.3 lakh crore in the last four months of FY21.“We continue to project the Centre's fiscal deficit for FY21 at Rs 14.5 lakh crore, which is equivalent to 7.5 per cent of our updated estimate of nominal GDP,” she said.